PortfoliosLab logo
AbbVie Inc. (ABBV)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US00287Y1091

CUSIP

00287Y109

IPO Date

Jan 2, 2013

Highlights

Market Cap

$326.55B

EPS (TTM)

$2.34

PE Ratio

78.89

PEG Ratio

0.39

Total Revenue (TTM)

$57.37B

Gross Profit (TTM)

$44.44B

EBITDA (TTM)

$16.33B

Year Range

$148.19 - $216.66

Target Price

$210.75

Short %

1.12%

Short Ratio

2.02

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

Returns By Period

AbbVie Inc. (ABBV) returned 8.97% year-to-date (YTD) and 22.54% over the past 12 months. Over the past 10 years, ABBV delivered an annualized return of 15.94%, outperforming the S&P 500 benchmark at 10.69%.


ABBV

YTD

8.97%

1M

9.58%

6M

11.01%

1Y

22.54%

5Y*

21.38%

10Y*

15.94%

^GSPC (Benchmark)

YTD

-0.64%

1M

8.97%

6M

-2.62%

1Y

11.90%

5Y*

15.76%

10Y*

10.69%

*Annualized

Monthly Returns

The table below presents the monthly returns of ABBV, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20254.46%13.67%0.23%-6.02%-2.58%8.97%
20247.10%7.09%3.44%-9.85%-0.86%6.38%9.04%5.93%0.60%4.07%-10.27%-2.86%18.87%
2023-7.71%4.16%3.55%-4.30%-8.71%-2.34%12.25%-1.75%1.43%-4.34%0.86%8.83%-0.23%
20222.15%7.95%9.70%-8.62%0.33%3.93%-5.42%-6.31%-0.19%10.19%10.10%0.27%24.01%
2021-3.24%5.13%0.45%4.28%1.52%-0.49%4.40%3.85%-10.69%7.59%0.53%17.45%32.43%
2020-7.26%5.79%-11.11%9.50%12.74%5.95%-2.15%0.91%-8.54%-1.52%22.89%2.46%27.72%
2019-11.84%-1.31%1.70%-0.18%-3.38%-5.20%-6.99%-1.32%15.18%6.59%10.28%0.92%1.47%
201816.87%3.22%-18.29%3.06%2.48%-6.36%0.56%4.07%-1.46%-16.81%21.09%-2.21%-0.96%
2017-1.43%1.19%5.37%2.20%0.12%9.83%-2.72%7.71%18.01%2.27%7.39%-0.22%60.07%
2016-6.35%-0.53%4.60%7.82%3.16%-1.62%7.92%-3.22%-1.61%-10.74%9.00%2.99%9.79%
2015-7.09%0.25%-3.24%11.37%2.98%0.90%4.97%-10.86%-12.82%10.46%-2.35%1.87%-6.50%
2014-6.04%3.41%0.96%2.23%4.32%3.88%-6.56%5.62%4.49%10.69%9.05%-5.43%27.92%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 78, ABBV is among the top 22% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of ABBV is 7878
Overall Rank
The Sharpe Ratio Rank of ABBV is 7979
Sharpe Ratio Rank
The Sortino Ratio Rank of ABBV is 7171
Sortino Ratio Rank
The Omega Ratio Rank of ABBV is 7575
Omega Ratio Rank
The Calmar Ratio Rank of ABBV is 8686
Calmar Ratio Rank
The Martin Ratio Rank of ABBV is 7777
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for AbbVie Inc. (ABBV) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

AbbVie Inc. Sharpe ratios as of May 13, 2025 (values are recalculated daily):

  • 1-Year: 0.82
  • 5-Year: 0.95
  • 10-Year: 0.60
  • All Time: 0.73

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of AbbVie Inc. compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Loading data...

Dividends

Dividend History

AbbVie Inc. provided a 3.36% dividend yield over the last twelve months, with an annual payout of $6.38 per share. The company has been increasing its dividends for 11 consecutive years.


2.50%3.00%3.50%4.00%4.50%5.00%$0.00$1.00$2.00$3.00$4.00$5.00$6.0020142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
Dividend$6.38$6.20$5.92$5.64$5.20$4.72$4.28$3.59$2.56$2.28$2.02$1.66

Dividend yield

3.36%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%

Monthly Dividends

The table displays the monthly dividend distributions for AbbVie Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$1.64$0.00$0.00$1.64$0.00$3.28
2024$1.55$0.00$0.00$1.55$0.00$0.00$1.55$0.00$0.00$1.55$0.00$0.00$6.20
2023$1.48$0.00$0.00$1.48$0.00$0.00$1.48$0.00$0.00$1.48$0.00$0.00$5.92
2022$1.41$0.00$0.00$1.41$0.00$0.00$1.41$0.00$0.00$1.41$0.00$0.00$5.64
2021$1.30$0.00$0.00$1.30$0.00$0.00$1.30$0.00$0.00$1.30$0.00$0.00$5.20
2020$1.18$0.00$0.00$1.18$0.00$0.00$1.18$0.00$0.00$1.18$0.00$0.00$4.72
2019$1.07$0.00$0.00$1.07$0.00$0.00$1.07$0.00$0.00$1.07$0.00$0.00$4.28
2018$0.71$0.00$0.00$0.96$0.00$0.00$0.96$0.00$0.00$0.96$0.00$0.00$3.59
2017$0.64$0.00$0.00$0.64$0.00$0.00$0.64$0.00$0.00$0.64$0.00$0.00$2.56
2016$0.57$0.00$0.00$0.57$0.00$0.00$0.57$0.00$0.00$0.57$0.00$0.00$2.28
2015$0.49$0.00$0.00$0.51$0.00$0.00$0.51$0.00$0.00$0.51$0.00$0.00$2.02
2014$0.40$0.00$0.00$0.42$0.00$0.00$0.42$0.00$0.00$0.42$0.00$0.00$1.66

Dividend Yield & Payout


Dividend Yield

AbbVie Inc. has a dividend yield of 3.36%, which is quite average when compared to the overall market.

Payout Ratio

AbbVie Inc. has a payout ratio of 62.12%, which is quite average when compared to the overall market. This suggests that AbbVie Inc. strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the AbbVie Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the AbbVie Inc. was 45.09%, occurring on Aug 15, 2019. Recovery took 330 trading sessions.

The current AbbVie Inc. drawdown is 11.46%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-45.09%Jan 29, 2018390Aug 15, 2019330Dec 4, 2020720
-31.61%Jul 29, 201561Oct 22, 2015383May 2, 2017444
-21.92%Apr 11, 2022120Sep 30, 2022320Jan 10, 2024440
-20.74%Mar 11, 202529Apr 21, 2025
-19.82%Dec 8, 201443Feb 9, 201590Jun 18, 2015133

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of AbbVie Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of AbbVie Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 2.6% positive surprise.


2.002.503.003.5020212022202320242025
2.46
2.40
Actual
Estimate

Valuation

The Valuation section provides an overview of how AbbVie Inc. is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for ABBV, comparing it with other companies in the Drug Manufacturers - General industry. Currently, ABBV has a P/E ratio of 78.9. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for ABBV compared to other companies in the Drug Manufacturers - General industry. ABBV currently has a PEG ratio of 0.4. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ABBV relative to other companies in the Drug Manufacturers - General industry. Currently, ABBV has a P/S ratio of 5.7. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for ABBV in comparison with other companies in the Drug Manufacturers - General industry. Currently, ABBV has a P/B value of 229.6. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items